These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7016788)

  • 1. Pressor factors and cardiovascular pressor reponsiveness in essential hypertension.
    Weidmann P
    Int J Obes; 1981; 5 suppl 1():51-67. PubMed ID: 7016788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.
    Weidmann P
    Klin Wochenschr; 1980 Oct; 58(19):1071-89. PubMed ID: 7453095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension].
    Philipp T
    Fortschr Med; 1979 Aug; 97(30-31):1315-20. PubMed ID: 468094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.
    Ajayi AA; Reid JL
    Int J Clin Pharmacol Res; 1988; 8(5):327-33. PubMed ID: 2852643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships of the renin angiotensin system and the sympathetic nervous system in the pathogenesis of hypertension in man-a hypothesis.
    Doyle AE; Louis WJ; Wilson M
    Clin Exp Pharmacol Physiol; 1975; Suppl 2():141-4. PubMed ID: 1183082
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
    Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Shaw S
    J Hum Hypertens; 1988 Mar; 1(4):267-76. PubMed ID: 3065505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH; Zukowska-Grojec Z; Kopin IJ; Feuerstein G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):85-90. PubMed ID: 6491978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressor factors and cardiovascular pressor responsiveness in borderline hypertension.
    Meier A; Weidmann P; Grimm M; Keusch G; Glück Z; Minder I; Ziegler WH
    Hypertension; 1981; 3(3):367-72. PubMed ID: 7019068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Review of research on essential hypertension].
    Yoshitoshi Y; Masuyama Y
    Nihon Rinsho; 1973 Nov; 31(11):3118-23. PubMed ID: 4360304
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
    Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Favre L; Vallotton M
    J Hypertens Suppl; 1986 Dec; 4(6):S310-3. PubMed ID: 3475419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic.
    Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
    J Hypertens Suppl; 1984 Dec; 2(3):S449-52. PubMed ID: 6599697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
    Matsukawa T; Mano T; Gotoh E; Ishii M
    J Clin Invest; 1993 Jul; 92(1):25-8. PubMed ID: 8325991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness.
    Schiffl H; Weidmann P; Beretta-Piccoli C; Cottier C; Seiler AJ; Ziegler WH
    Eur J Clin Pharmacol; 1982; 23(3):215-20. PubMed ID: 6756933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.
    Conway J
    Brux Med; 1973 Nov; Spec No(0):87-98. PubMed ID: 4371910
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance.
    Brunner HR; Gavras H; Ribeiro AB; Posternak L
    Prog Biochem Pharmacol; 1976; 12():145-62. PubMed ID: 1019161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin system and aldosterone in hypertension: a brief review of some aspects.
    Fraser R; Brown JJ; Lever AF; Morton JJ; Robertson JI
    Int J Obes; 1981; 5 suppl 1():115-23. PubMed ID: 7016779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular reactivity to angiotensin in borderline hypertension.
    Safar M; London G; Weiss Y; Simon A; Milliez P
    Biomedicine; 1974 Dec; 21(12):491-4. PubMed ID: 4376972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.